Bile acids and gut bacteria in C. difficile with ulcerative colitis
Part of Digestive system, Infections clinical trials.
This study looks at how bile acids and gut bacteria relate to C. difficile infection in children with ulcerative colitis. It aims to find better ways to predict and treat these infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is under 18 years old and cared for at Necker-Enfants Malades Hospital.
- Your child has ulcerative colitis (UC) that is either in a flare (active symptoms) or in remission (no symptoms).
- Your child has not taken antibiotics or antifungal medicines in the last 4 weeks.
- Your child does not have a known C. difficile infection (without symptoms).
- Your child has not had their colon removed (colectomy) and does not have other liver diseases like sclerosing cholangitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether transferring healthy gut bacteria (a fecal microbiome transplant) can help children with repeated or moderate-to-severe C. difficile infection. It focuses on changing gut bacteria to reduce ongoing infection and symptoms.
This trial tests whether one or multiple fecal transplants from a healthy donor can help treat both a recurring C. diff infection and active ulcerative colitis. It aims to find the best schedule for the procedure.
This trial studies whether transferring healthy stool bacteria into the gut (fecal microbiota transplantation, or FMT) can improve symptoms in children with ulcerative colitis. It may help by changing gut bacteria, especially for children who are newly diagnosed or who didn’t respond to standard treatments.
This study looks at how changes in gut bacteria (the microbiome) relate to inflammatory bowel disease, including ulcerative colitis and Crohn disease. It may help researchers understand what might improve symptoms or disease control.
This trial tests whether giving children with ulcerative colitis a transplant of healthy donor stool (fecal microbiota transplant) can help control their disease. It aims to see if this treatment can reduce inflammation in the gut.
This study uses fecal microbiota transplantation (FMT) — transferring gut bacteria from a healthy donor — to see how it affects the gut microbiome in people with ulcerative colitis, metabolic syndrome, or recurrent C. difficile infection. It may help stabilize the gut bacteria and improve symptoms.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.